# A Long-Term Safety Follow-Up Study for Patients Treat With WU-CART-007

> **NCT05509855** · — · ENROLLING_BY_INVITATION · sponsor: **Wugen, Inc.** · enrollment: 44 (estimated)

## Conditions studied

- T-cell Acute Lymphoblastic Leukemia
- T-cell Lymphoblastic Lymphoma

## Interventions

- **GENETIC:** Genetic: WU-CART-007

## Key facts

- **NCT ID:** NCT05509855
- **Lead sponsor:** Wugen, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2022-08-22
- **Primary completion:** 2037-07-01
- **Final completion:** 2037-07-01
- **Target enrollment:** 44 (ESTIMATED)
- **Last updated:** 2024-11-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05509855

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05509855, "A Long-Term Safety Follow-Up Study for Patients Treat With WU-CART-007". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05509855. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*